46
Views
2
CrossRef citations to date
0
Altmetric
Original Research

DDMC-p53 gene therapy with or without cisplatin and microwave ablation

, , , , , , , , , , , & show all
Pages 1165-1173 | Published online: 20 May 2015

References

  • DavisKLGoyalRKAbleSLBrownJLiLKayeJAReal-world treatment patterns and costs in a US Medicare population with metastatic squamous non-small cell lung cancerLung Cancer1182014 Epub ahead of print
  • TsioudaTZarogoulidisPPetridisDA multifactoral analysis of 1452 patients for smoking sensation. An outpatient lab experienceJ Cancer20145643344524847384
  • ZarogoulidisKZarogoulidisPDarwicheKTreatment of non-small cell lung cancer (NSCLC)J Thorac Dis20135Suppl 4S389S39624102012
  • ZarogoulidisPTsakiridisKZarogoulidisKLung cancer: an update on current and future diagnostic and treatment techniquesJ Thorac Dis20135Suppl 4S34124102006
  • BaltayiannisNChandrinosMAnagnostopoulosDLung cancer surgery: an up to dateJ Thorac Dis20135Suppl 4S425S43924102017
  • KallianosARaptiAZarogoulidisPTherapeutic procedure in small cell lung cancerJ Thorac Dis20135Suppl 4S420S42424102016
  • BoutsikouEKontakiotisTZarogoulidisPDocetaxel-carboplatin in combination with erlotinib and/or bevacizumab in patients with non-small cell lung cancerOnco Targets Ther2013612513423467839
  • DomvriKZarogoulidisPDarwicheKMolecular targeted drugs and biomarkers in NSCLC, the evolving role of individualized therapyJ Cancer2013473675424312144
  • ZarogoulidisPDarwicheKKraussLInhaled cisplatin deposition and distribution in lymph nodes in stage II lung cancer patientsFuture Oncol2013991307131323980678
  • ZarogoulidisPDarwicheKHohenforst-SchmidtWInhaled gene therapy in lung cancer: proof-of-concept for nano-oncology and nano-biotechnology in the management of lung cancerFuture Oncol2013981171119423902248
  • Hohenforst-SchmidtWZarogoulidisPDarwicheKIntratumoral chemotherapy for lung cancer: re-challenge current targeted therapiesDrug Des Devel Ther20137571583
  • ZaricBStojsicVTepavacAAdjuvant chemotherapy and radiotherapy in the treatment of non-small cell lung cancer (NSCLC)J Thorac Dis20135Suppl 4S371S37724102009
  • ZaricBStojsicVKovacevicTClinical characteristics, tumor, node, metastasis status, and mutation rate in domain of epidermal growth factor receptor gene in serbian patients with lung adenocarcinomaJ Thorac Oncol201491406141025122436
  • BoukovinasITsakiridisKZarogoulidisPNeo-adjuvant chemotherapy in early stage non-small cell lung cancerJ Thorac Dis20135Suppl 4S446S44824102019
  • ZarogoulidisKLatsiosDPorpodisKNew dilemmas in small-cell lung cancer TNM clinical stagingOnco Targets Ther2013653954723700372
  • LithoxopoulouHZarogoulidisKBostantzopoulouSMonitoring changes in quality of life in patients with lung cancer by using specialised questionnaires: implications for clinical practiceSupport Care Cancer2014222177218324652050
  • MillerPJBaluSBuchnerDWalkerMSStepanskiEJSchwartzbergLSWillingness to pay to prevent chemotherapy induced nausea and vomiting among patients with breast, lung, or colorectal cancerJ Med Econ2013161179118923919632
  • GrossiFGenovaCGaitanNDFree drugs in clinical trials and their potential cost saving impact on the National Health Service: a retrospective cost analysis in ItalyLung Cancer20138123624023648072
  • ZarogoulidouVPanagopoulouEPapakostaDEstimating the direct and indirect costs of lung cancer: a prospective analysis in a Greek University Pulmonary DepartmentJ Thorac Dis20157Suppl 1S12S1925774302
  • PorpodisKKaranikasMZarogoulidisPA case of typical pulmonary carcinoid tumor treated with bronchoscopic therapy followed by lobectomyJ Multidiscip Healthc20125475122396625
  • MavroudiMZarogoulidisPPorpodisKStem cells’ guided gene therapy of cancer: new frontier in personalized and targeted therapyJ Cancer Res Ther (Manch)20142223324860662
  • Hohenforst-SchmidtWZarogoulidisPLinsmeierBEnhancement of aerosol cisplatin chemotherapy with gene therapy expressing ABC10 protein in respiratory systemJ Cancer2014534435024723977
  • ZarogoulidisPDarwicheKSakkasASuicide gene therapy for cancer – current strategiesJ Genet Syndr Gene Ther20134pii 16849
  • BaliakaAZarogoulidisPDomvriKIntratumoral gene therapy versus intravenous gene therapy for distant metastasis control with 2-diethylaminoethyl-dextran methyl methacrylate copolymer non-viral vector-p53Gene Ther20142115816724285215
  • ZarogoulidisPPetridisDRitzoulisCEstablishing the optimal nebulization system for paclitaxel, docetaxel, cisplatin, carboplatin and gemcitabine: back to drawing the residual cupInt J Pharm201345348048723769993
  • DarwicheKZarogoulidisPKaramanosNKEfficacy versus safety concerns for aerosol chemotherapy in non-small-cell lung cancer: a future dilemma for micro-oncologyFuture Oncol2013950552523560374
  • ZarogoulidisPChatzakiEPorpodisKInhaled chemotherapy in lung cancer: future concept of nanomedicineInt J Nanomedicine201271551157222619512
  • ZarogoulidisPEleftheriadouESapardanisIFeasibility and effectiveness of inhaled carboplatin in NSCLC patientsInvest New Drugs2012301628164021739158
  • ZarogoulidisPGiraleliCKaramanosNKInhaled chemotherapy in lung cancer: safety concerns of nanocomplexes deliveredTher Deliv201231021102323035587
  • ZarogoulidisPKontakiotisTZarogoulidisKInhaled gene therapy in lung cancer: “as for the future, our task is not to foresee it, but to enable it”Ther Deliv2012391992122946426
  • ZarogoulidisPDarwicheKYarmusLDefense mechanisms of the respiratory system and aerosol production systemsMed Chem20141012313624007475
  • ZarogoulidisPPapanasNKouliatsisGSpyratosDZarogoulidisKMaltezosEInhaled insulin: too soon to be forgotten?J Aerosol Med Pulm Drug Deliv20112421322321689020
  • BaeYHInterview with Dr You Han Bae: ligand-mediated versus ‘passive’ targeting approaches in nanoparticle oncology researchTher Deliv2012393393622946427
  • PalussiereJLagardePAuperinADeschampsFChomyFde BaereTPercutaneous lung thermal ablation of non-surgical clinical N0 non-small cell lung cancer: results of eight years’ experience in 87 patients from two centersCardiovasc Intervent Radiol20153816016625394595
  • AndreettiCMauriziGCassianoFRendinaEAResolution of a life-threatening complication after lung radiofrequency ablationEur J Cardiothorac Surg201446e56e5825086104
  • SolazzoSAAhmedMSchor-BardachRLiposomal doxorubicin increases radiofrequency ablation-induced tumor destruction by increasing cellular oxidative and nitrative stress and accelerating apoptotic pathwaysRadiology2010255627420160000
  • SimHBibeeKWicklineSSeptDPharmacokinetic modeling of tumor bioluminescence implicates efflux, and not influx, as the bigger hurdle in cancer drug therapyCancer Res20117168669221123454
  • StylianopoulosTEPR-effect: utilizing size-dependent nanoparticle delivery to solid tumorsTher Deliv2013442142323557281
  • FangJQinHNakamuraHTsukigawaKShinTMaedaHCarbon monoxide, generated by heme oxygenase-1, mediates the enhanced permeability and retention effect in solid tumorsCancer Sci201210353554122145952
  • ZhaoWZhuangSQiXRComparative study of the in vitro and in vivo characteristics of cationic and neutral liposomesInt J Nanomedicine201163087309822163162
  • Hohenforst-SchmidtWZarogoulidisPStopekJEnhancement of intratumoral chemotherapy with cisplatin with or without microwave ablation and lipiodol. Future concept for local treatment in lung cancerJ Cancer2015621822625663938
  • ZarogoulidisPHohenforst-SchmidtWDarwicheK2- diethylaminoethyl-dextran methyl methacrylate copolymer nonviral vector: still a long way toward the safety of aerosol gene therapyGene Ther2013201022102823719068
  • SakkasAZarogoulidisPDomvriKSafety and efficacy of suicide gene therapy with adenosine deaminase 5-fluorocytosine silmutaneously in in vitro cultures of melanoma and retinal cell linesJ Cancer2014536838124799955
  • DomvriKZarogoulidisPTheodoropoulosFHuangHZarogoulidisKEstablishment of a malignant pleural effusion mouse model: pathogenesis pathwaysTransl Lung Cancer Res2012116316625806177
  • BertramJSJanikPEstablishment of a cloned line of Lewis lung carcinoma cells adapted to cell cultureCancer Lett19801163737226139
  • ZarogoulidisPChatzakiEHohenforst-SchmidtWManagement of malignant pleural effusion by suicide gene therapy in advanced stage lung cancer: a case series and literature reviewCancer Gene Ther20121959360022744209
  • VenturaAMeissnerADillonCPCre-lox-regulated conditional RNA interference from transgenesProc Natl Acad Sci U S A2004101103801038515240889
  • EshitaYHigashiharaJOnishiMMechanism of the introduction of exogenous genes into cultured cells using DEAE-dextran-MMA graft copolymer as a non-viral gene carrier. II. Its thixotropy propertyJ Nanomed Nanotechnol20112104
  • OnishiYEshitaYMurashitaAMizunoMYoshidaJSynthesis and characterization of 2-diethyl-aminoethyl-dextran-methyl methacrylate graft copolymer for nonviral gene delivery vectorJ Appl Polym Sci200598914
  • VeenstraJJGibsonHMFreytagSLittrupPJWeiWZIn situ immunization via non-surgical ablation to prevent local and distant tumor recurrenceOncoimmunology201543e98976225949901
  • ZarogoulidisPLampakiSTurnerJFmTOR pathway: a current, up-to-date mini-reviewOncol Lett201482367237025360163
  • LeiflerKSSvenssonSAbrahamssonAInflammation induced by MMP-9 enhances tumor regression of experimental breast cancerJ Immunol20131904420443023509357
  • PengYFShiYHDingZBAlpha-fetoprotein promoter-driven Cre/LoxP-switched RNA interference for hepatocellular carcinoma tissue-specific target therapyPLoS One20138e5307223468839
  • ChenQChengPSongNAntitumor activity of placenta-derived mesenchymal stem cells producing pigment epithelium-derived factor in a mouse melanoma modelOncol Lett2012441341823741242
  • LiHNakashimaHDeckleverTDNaceRARussellSJHSV-NIS, an oncolytic herpes simplex virus type 1 encoding human sodium iodide symporter for preclinical prostate cancer radiovirotherapyCancer Gene Ther20132047848523868101
  • HallettMATengBHasegawaHSchwabLPSeagrovesTNPourmotabbedTAnti-matrix metalloproteinase-9 DNAzyme decreases tumor growth in the MMTV-PyMT mouse model of breast cancerBreast Cancer Res201315R1223407024
  • PuntelMAKMGFarrokhiCSafety profile, efficacy, and biodistribution of a bicistronic high-capacity adenovirus vector encoding a combined immunostimulation and cytotoxic gene therapy as a prelude to a phase I clinical trial for glioblastomaToxicol Appl Pharmacol201326831833023403069
  • HuangSShaoKKuangYTumor targeting and microenvironment-responsive nanoparticles for gene deliveryBiomaterials2013345294530223562171
  • RamachandranMYuDWandersAEssandMErikssonFAn infection-enhanced oncolytic adenovirus secreting H. pylori neutrophil-activating protein with therapeutic effects on neuroendocrine tumorsMol Ther2013212008201823817216
  • KasaiKNakashimaHLiuFToxicology and biodistribution studies for MGH2.1, an oncolytic virus that expresses two prodrug-activating genes, in combination with prodrugsMol Ther Nucleic Acids20132e11323922029
  • ChirmuleNHughesJVGaoGPRaperSEWilsonJMRole of E4 in eliciting CD4 T-cell and B-cell responses to adenovirus vectors delivered to murine and nonhuman primate lungsJ Virol199872613861459621078
  • YangWAhmedMElianMDo liposomal apoptotic enhancers increase tumor coagulation and end-point survival in percutaneous radiofrequency ablation of tumors in a rat tumor model?Radiology201025768569620858851
  • Le PivertPJMorrisonDRHaddadRSPercutaneous tumor ablation: microencapsulated echo-guided interstitial chemotherapy combined with cryosurgery increases necrosis in prostate cancerTechnol Cancer Res Treat2009820721619445538
  • LinXGaoRZhangYLipid nanoparticles for chemotherapeutic applications: strategies to improve anticancer efficacyExpert Opin Drug Deliv2012976778122554018
  • XieHGoinsBBaoAWangZJPhillipsWTEffect of intratumoral administration on biodistribution of 64Cu-labeled nanoshellsInt J Nanomedicine201272227223822619558
  • ZouYTornosCQiuXLiaMPerez-SolerRp53 aerosol formulation with low toxicity and high efficiency for early lung cancer treatmentClin Cancer Res2007134900490817699870
  • FrederiksenKSAbrahamsenNCristianoRJDamstrupLPoulsenHSGene delivery by an epidermal growth factor/DNA polyplex to small cell lung cancer cell lines expressing low levels of epidermal growth factor receptorCancer Gene Ther2000726226810770635
  • KimHWParkIKChoCSAerosol delivery of glucosylated polyethylenimine/phosphatase and tensin homologue deleted on chromosome 10 complex suppresses Akt downstream pathways in the lung of K-ras null miceCancer Res2004647971797615520204
  • GautamADensmoreCLMeltonSGolunskiEWaldrepJCAerosol delivery of PEI-p53 complexes inhibits B16-F10 lung metastases through regulation of angiogenesisCancer Gene Ther20029283611916242
  • Horev-DroriGCooksTBittanHLocal control of experimental malignant pancreatic tumors by treatment with a combination of chemotherapy and intratumoral 224radium-loaded wires releasing alpha-emitting atomsTransl Res2012159324122153808
  • AhmedMMoussaMGoldbergSNSynergy in cancer treatment between liposomal chemotherapeutics and thermal ablationChem Phys Lipids201216542443722197685
  • SonCHShinDYKimSDImprovement of antitumor effect of intratumoral injection of immature dendritic cells into irradiated tumor by cyclophosphamide in mouse colon cancer modelJ Immunother20123560761422996366
  • RautCPBoucherYDudaDGEffects of sorafenib on intratumoral interstitial fluid pressure and circulating biomarkers in patients with refractory sarcomas (NCI protocol 6948)PLoS One20127e2633122347360
  • BettingDJHurvitzSAStewardKKCombination of cyclophosphamide, rituximab, and intratumoral CpG oligodeoxynucleotide successfully eradicates established B cell lymphomaJ Immunother20123553454322892450
  • LaiCYFiteBZFerraraKWUltrasonic enhancement of drug penetration in solid tumorsFront Oncol2013320423967400
  • ShengSZhengJCuiSCuiXQianZComplete remission of multiple lung metastases after ablation of hepatocellular carcinoma by transarterial infusion with the p53 geneAnticancer Drugs20152622723125243455
  • AcksteinerCSteinkeKPercutaneous microwave ablation for early-stage non-small cell lung cancer (NSCLC) in the elderly: a promising outlookJ Med Imaging Radiat Oncol201559829025335916
  • SchneiderTThermal ablation of malignant lung tumoursZentralbl Chir2015140104108 German25329865
  • WinokurRSDuJYPuaBBCharacterization of in vivo ablation zones following percutaneous microwave ablation of the liver with two commercially available devices: are manufacturer published reference values useful?J Vasc Interv Radiol20142519391946.e125307296
  • WuWXueYWangDXueJZhaiWLiangPA simulator for percutaneous hepatic microwave thermal ablation under ultrasound guidanceInt J Hyperthermia201419
  • LeungUKukDD’AngelicaMILong-term outcomes following microwave ablation for liver malignanciesBr J Surg2015102859125296639
  • FarinaLWeissNNissenbaumYCharacterisation of tissue shrinkage during microwave thermal ablationInt J Hyperthermia2014110
  • ItoKSaitoKDevelopment of microwave antennas for thermal therapyCurr Pharm Des2011172360236621736543